Skip to main content
TipRanks
Go Ultimate75% OFF

Santhera Pharmaceuticals Holding (SPHDF) Stock Forecast & Price Target

40 Followers
See the Price Targets and Ratings of:

SPHDF Analyst Ratings

Currently, no data available

SPHDF Stock 12 Month Forecast

There Are No Analyst Ratings for SPHDF In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for SPHDF
Price TargetArticle
H.C. Wainwright$35.70buy95.06%UpsideReiterated07/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IMUXImmunic
MDWDMediwound
PTGXProtagonist Therapeutics
KRSAKorsana Biosciences
AXGNAxoGen

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Santhera Pharmaceuticals Holding

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate3/7 ratings generated profit
43%
Average Return
+7.97%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +7.97% per trade.

1 Year
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate4/7 ratings generated profit
57%
Average Return
+13.36%

Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +13.36% per trade.

2 Years
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate4/7 ratings generated profit
57%
Average Return
+8.94%

Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +8.94% per trade.

SPHDF Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for SPHDF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy22100
Buy00000
Hold00000
Sell00000
Strong Sell00000
total22100

In the current month, SPHDF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SPHDF average Analyst price target in the past 3 months is ―.

SPHDF Financial Forecast

$-5$-3.75$-2.5$-1.25$0Q2 2025Q2 2026Q4 2026
Consensus$-1.81

SPHDF Earnings Forecast

Next quarter’s earnings estimate for SPHDF is -$1.81 with a range of ― to ―. The previous quarter’s EPS was -$1.81. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$28.9M$37.7M$46.5M$55.2M$64MQ2 2025Q2 2026Q4 2026
High$44.4M
Consensus$44.4M
Low$44.4M

SPHDF Sales Forecast

Next quarter’s sales forecast for SPHDF is $44.42M with a range of $44.42M to $44.42M. The previous quarter’s sales results were $58.18M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

SPHDF Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Santhera Pharmaceuticals Holding?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of SPHDF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.